Marius Rosenberg

CPO | Ecosystem Architect | Entrepreneur

📍 Germany🔄 Updated September 2026💼 5 investments📅 12 years investing🗓 Last invested May 2025
Operator-angel🌍 Germany
5
Total investments
1
Early stage
2
Mid stage
0
Late stage
12y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2023
XO Life stands for ✅ a state-of-the-art platform solution for long-term Patient Insights from the real world ✅ real time information exchange between patients and pharma ✅ a all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold standard in R&D, marketing and sales, while ensuring the highest data protection and security standards. ➡️ Join us in shaping the future of patient centered medical data collection and learn more at:
Co-Initiator & Investor
May 2022
We believe the future belongs to entrepreneurs who dare to solve the most pressing challenges of our time—those who bolster Europes sovereignty, leverage breakthroughs in science and technology, and work to enhance both human and planetary health. Our mission is clear: building Europes No. 1 marketplace for Deep Tech capital and customers. We’re hiring: https://dtm-jobs.super.site/
Beiratsvorsitzender & Investor
Oct 2020
At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!
mid stageBiotechnology
Co-Founder and Investor
May 2014
Mapudo is the market place for metals. We are addressing both metals suppliers and B2B buyers, reaching from small workshops to global manufacturing companies. With the metals supply industry, Mapudo supports one of the most important and traditional industries on its transformational way to digitalization, especially in the distribution process. Tailor-made solutions, accounting for the specific requirements of this challenging market, promise an enormous potential in reducing transaction costs for both suppliers and buyers.  Mapudo was founded in 2014 and is backed by renowned investors, industry experts and a dedicated team of hands-on entrepreneurs. As an agile and fast-growing company, Mapudo is on an extremely demanding and rewarding journey to become the leading materials marketplace available.  Imprint: https://www.mapudo.com/unternehmen/impressum
Experience · 8 entries
All (8)
Investments (4)
Founder (2)
Board (2)
2025
Board Member
May 2025
Bionorica is one of the leading manufacturers of herbal remedies in the world. Our claim is to make modern medicine a bit more plant-based for the health of people every day. We combine modern pharmaceutical research with the effectiveness of plants. For more than 85 years, we have been producing highly effective and well-tolerated phytopharmaceuticals. The starting point and reference point of Bionorica is nature. Thus, it is the vision and mission of Professor Michael A. Popp, CEO and owner of Bionorica, to decode nature and bring its immeasurable healing and health preserving power back to people. Bionorica unlocks the huge potential of active ingredients in plants by using cutting-edge research and innovative technologies to produce effective and safe herbal medicines. We call this Phytoneering. Social Media Community Guideline and Privacy Policy: https://bionorica.com/service/social-media.html Legal notice: https://bionorica.com/service/legal-notice.html
2023
Board Member
Jan 2023
XO Life stands for ✅ a state-of-the-art platform solution for long-term Patient Insights from the real world ✅ real time information exchange between patients and pharma ✅ a all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold standard in R&D, marketing and sales, while ensuring the highest data protection and security standards. ➡️ Join us in shaping the future of patient centered medical data collection and learn more at:
2022
Co-Initiator & Investor
May 2022
We believe the future belongs to entrepreneurs who dare to solve the most pressing challenges of our time—those who bolster Europes sovereignty, leverage breakthroughs in science and technology, and work to enhance both human and planetary health. Our mission is clear: building Europes No. 1 marketplace for Deep Tech capital and customers. We’re hiring: https://dtm-jobs.super.site/
2021
Managing Director Excellence Startup Center @ RWTH Aachen
Jan 2021
Entrepreneurial Transfer at RWTH Aachen University We support researchers, inventors and founders of RWTH Aachen University with individual and diverse service offers helping them develop their ideas and research results to a market-ready technology. Furthermore, we help business partners of RWTH Aachen University find their way within the university landscape and support them in their search for and cooperation with suitable research partners. Stay curiuos & dont stop innovating. _________________________________________ This LinkedIn page is supervised by the Communications Management Team of RWTH Innovation. You can reach us via: communications@rwth-innovation.de
2020
Beiratsvorsitzender & Investor
Oct 2020
At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!
mid stageBiotechnology
Show all 8 entries ↓
Investment activity
2014–2025 · 5 investments
2014120201202212023120251
Recent (last 2 years)Earlier